• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

Topelia

Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox
October 16, 2021
Pharmaceutical News

Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox

SYDNEY,Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment program designed to keep the invention Australian owned – while rolling out treatment to the world. – Topelia announces US$25 mil Series A capital

More
Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox
Pharmaceutical News

Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox

October 16, 2021

SYDNEY,Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment

More
  • APAC overview: trends, challenges, and possibilities for growth in the MarTech sector
  • Modernizing Therapeutic Cell Production
  • Neuraxpharm completes its presence in Benelux
  • Pharma Mirror Q&A with Jane Myles, Vice President of Clinical Trial Innovation at Curebase
  • Leg Veins: Why They Appear and How Vein Doctors Treat Them?

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop